Antibody breaks leukemia's hold, providing new therapeutic approach
Acute myeloid leukemia (AML) is an aggressive cancer known for drug resistance and relapse. In an effort to uncover new treatment strategies, researchers at University of California San Diego School of Medicine and Moores ...
Oct 27, 2016
0
4